Agilent Technologies to Sponsor Life Science Workshops in San Diego, San Francisco Bay Area on Dec. 11 and 12
Top Researchers to Present Integrated Approaches to Disease Research, Drug Development
SANTA CLARA, Calif., Dec. 9, 2013
Agilent Technologies Inc. (NYSE: A) today announced it will host two life science workshops in California this month. The first, 'Omics Approaches in Understanding Disease, will be held in San Diego on Wednesday, Dec. 11. The San Francisco Bay Area workshop, Implementing Multi-Omics Approaches-From Discovery to Clinical Research, will be held Dec. 12. Guests will hear presentations from leading scientists using Agilent's latest integrated biology technologies to gain new insights into drug development and disease research.
"These exciting events are designed for life scientists and clinicians involved in translational research and others interested in learning more about the power of pathway-guided multi-omics approaches to understanding the biological mechanisms of diseases," said Leo Bonilla, Agilent's director of Integrated Biology.
At both workshops, Dr. Robert Gerszten, director of Clinical and Translational Research at Massachusetts General Hospital Institute for Heart, Vascular and Stroke Care, and professor of medicine at Harvard Medical School, will discuss how his team is applying multi-omics technologies to the study of cardiovascular and metabolic diseases.
Antoni Wandycz, Agilent's director of Bioinformatics Solutions, will also present at both events. He will demonstrate how the company's powerful GeneSpring GX statistical software tools enable rapid visualization and analysis of transcriptomics, genomics, proteomics and metabolomics data.
At the Dec. 11 workshop in San Diego, Dr. Gary Siuzdak, professor of Chemistry, Molecular and Computational Biology and senior director of Scripps Center for Metabolomics and Mass Spectrometry, will review a unique, metabolomics-based biochemical approach to understanding disease pathogenesis.
At the Dec. 12 workshop in the San Francisco Bay Area, Dr. Carlito Lebrilla, professor at UC Davis School of Medicine, will discuss how his team is developing mass-spectrometry-based tools for cancer and nutrition research.
Also at the Dec. 12 workshop, Dr. Roger Linington, associate professor of chemistry and biochemistry at UC Santa Cruz, will present his latest multi-omics research on infectious diseases, such as malaria and tuberculosis. Dr. Linington's work focuses on natural marine products as a source of inspiration and innovation in biomedical science and drug discovery.
The Dec. 11 event will be held at Sanford Auditorium at the Sanford Consortium for Regenerative Medicine in La Jolla. The Dec. 12 event will be held at the Crown Plaza Hotel in Foster City. Customers, students and all interested guests are invited to attend both workshops and luncheons.
To register and learn more about both events, please visit Agilent Technologies Integrated Biology Symposia website.
About Agilent's Integrated Biology Solutions
Agilent provides researchers with analytical products that span all four major "omics" disciplines. These combined hardware/software and informatics solutions are fueling the next generation of pathway-centric multi-omics research and yielding valuable information about drug responses, drug resistance, diagnostic markers, and fundamental disease/toxicity pathways. For more information about Agilent's complete portfolio of integrated biology solutions, visit http://biology.chem.agilent.com.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is the world's premier measurement company and a technology leader in chemical analysis, life sciences, diagnostics, electronics and communications. The company's 20,600 employees serve customers in more than 100 countries. Agilent had revenues of $6.8 billion in fiscal 2013. Information about Agilent is available at www.agilent.com.
On Sept. 19, 2013, Agilent announced plans to separate into two publicly traded companies through a tax-free spinoff of its electronic measurement company. The separation is expected to be completed in early November 2014.
# # #
+1 408 553 7093